Skip to content

Study · In vitro (cells) · mouse · 1992

4 results

[Levamin and cerebrolysin as immunostimulants].

Belokrylov GA, Malchanova IV

Biulleten' eksperimental'noi biologii i meditsiny1 Feb 1992

PMID1611065 (opens in a new tab)DOI10.1007/bf00791503 (opens in a new tab)PepBankPUB-01611065
Publisher pagePubMedAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Activity measurement

    In mouse bone marrow cells, in vitro cerebrolysin treatment increased the number of Thy-1 positive cells.

    In plain wordsIn cells from mouse bone marrow, cerebrolysin increased the number of Thy-1 positive cells.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseThy-1 positive cell number
    Study

    mousen: not reported in source

    Mouse bone marrow cells
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The experiments on mice have shown that the in vitro treatment of mouse bone marrow cells with levamin or cerebrolysin (amino acids mixture) increased the number of Thy-1 positive cells and stimulated the in vivo immune response to SRBC.

Studies that did not test the peptide alone3

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 02AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In mice, in vitro treatment of bone marrow cells with cerebrolysin stimulated the in vivo immune response to SRBC.

    In plain wordsIn mice, bone marrow cells treated with cerebrolysin stimulated the immune response to SRBC.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseImmune response to SRBC
    Study

    mousen: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    The experiments on mice have shown that the in vitro treatment of mouse bone marrow cells with levamin or cerebrolysin (amino acids mixture) increased the number of Thy-1 positive cells and stimulated the in vivo immune response to SRBC.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  2. 03AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Activity measurement

    In mouse experiments involving cell treatment and immune responses, cerebrolysin showed less overall immunostimulant activity than levamin.

    In plain wordsIn mouse experiments, cerebrolysin showed less overall immunostimulant activity than levamin.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseRelative immunostimulant activity
    Study

    mousen: not reported in source

    Mouse immunostimulant experiments
    Comparator
    Levamin
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Levamin proved more active.
    1 context sentence
    Summary · context
    The experiments on mice have shown that the in vitro treatment of mouse bone marrow cells with levamin or cerebrolysin (amino acids mixture) increased the number of Thy-1 positive cells and stimulated the in vivo immune response to SRBC.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  3. 04AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In mice, cerebrolysin had no effect on the immune response to thymus-independent Vi-antigen.

    In plain wordsIn mice, cerebrolysin had no effect on the immune response to thymus-independent Vi-antigen.

    Peptide
    Cerebrolysin
    Outcome
    No significant changeImmune response to Vi-antigen
    Study

    mousen: not reported in source

    Mouse immune response
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    At the same time levamin and cerebrolysin had no effect on the immune response to thymus-independent Vi-antigen.
    1 context sentence
    Summary · context
    The experiments on mice have shown that the in vitro treatment of mouse bone marrow cells with levamin or cerebrolysin (amino acids mixture) increased the number of Thy-1 positive cells and stimulated the in vivo immune response to SRBC.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.